Yang Li
Following Mr. Liu’s resignation, Mr. Yang Li serves as the sole Chief Executive Officer of the Company.
Highest-materiality recent filing
Lakeside raises $5.88M in private placement; appoints Yang Li as joint CEO
Private placement of 8,400,000 shares at $0.70 each for aggregate proceeds of $5.88 million.
Lakeside Holding regains Nasdaq minimum bid price compliance
Received deficiency letter July 28, 2025 for bid price below $1.00 for 30 consecutive days.
Lakeside Holding corrects private placement terms: 2M shares at $0.75 each
Original filing reported 1.5M shares at $1.00; amended to 2.0M shares at $0.75 per share.
Lakeside raises $1.5M in private placement of 1.8M shares at $0.83/share
Issued 1,807,229 shares at $0.83 per share for aggregate proceeds of $1.5M.
Lakeside Holding receives Nasdaq bid-price deficiency notice; 180 days to cure
Notice received July 28, 2025; closing bid price below $1.00 for 30 consecutive business days since June 12.
Lakeside Holding regains Nasdaq minimum shareholders' equity compliance
Nasdaq confirmed on July 24, 2025 that Lakeside meets the $2,500,000 minimum stockholders' equity requirement.
Lakeside Holding raises $1.5M in private placement of 1.5M shares at $1.00/share
Issued 1,500,000 shares at $1.00 per share for aggregate proceeds of $1,500,000.
Lakeside raises ~$3M via 3M share issuance to regain Nasdaq equity compliance
Issued 3,000,000 shares of common stock for proceeds of approximately $3 million on June 27, 2025.
Lakeside Holding raises $3M via private placement of 3M shares at $1.00 each
Issued 3,000,000 shares at $1.00 per share for gross proceeds of $3,000,000.
Lakeside Q3 FY2025 revenue falls 15% to $3.8M; net loss of $1.07M vs prior profit
Total revenue $3.80M, down from $4.46M YoY; cross-border freight fell 26%, pharma distribution added $0.50M.
Lakeside (LSH) secures up to $4.5M convertible note financing with 7% OID and warrants
First tranche closed: $1M note and warrants for 318,827 shares at $1.9098, net proceeds $930k.
Lakeside Holding receives Nasdaq deficiency notice for insufficient stockholders' equity
Stockholders' equity of $1,646,281 as of Dec 31, 2024 is below Nasdaq's $2.5 million minimum.
Lakeside Q2 revenue fell 27% to $3.6M; net loss $1.9M vs prior-year profit
Q2 revenue $3.6M down 26.9% YoY; net loss $1.9M vs net income $0.06M.
Lakeside Q1 FY2025 revenue down 1.6%, net loss quadruples to $1.3M
Total revenue $4.08M, down 1.6% YoY; net loss widened to $1.3M from $0.3M.
Lakeside subsidiary to acquire 100% of Hupan Pharmaceutical for RMB4M (US$0.6M)
Lakeside's subsidiary Sichuan Hupan signs deal to acquire 100% of Hupan Pharmaceutical for RMB4.0M (US$0.6M).
Lakeside Holding FY2024 revenue up 42.3% to $18.3M; net loss of $0.2M vs prior net income
Revenue $18.3M, +42.3% YoY; airfreight surged 117.6% to $10.4M.
Following Mr. Liu’s resignation, Mr. Yang Li serves as the sole Chief Executive Officer of the Company.
Henry Liu, who currently serves as one of the Company’s Co-Chief Executive Officers, provided notice to the Company of his resignation as Co-Chief Executive Officer, effective June 2, 2026.
The Board resolved to appoint Mr. Long (Leo) Yi, who currently serves as the Chief Financial Officer of the Company, and Mr. Lan Su, who currently serves as the Chief Operating Officer of the Company, as new directors to fill vacancies on the Board, effective March 14 , 2025.
Mr. Henry Liu resigned from his position as the chairman and a member of the board of directors (the “Board”) of Lakeside Holding Limited (the “Company”), effective March 14 , 2025.
Mr. Shuai Li resigned from his position as a member of the Board, effective March 14 , 2025.
The Board resolved to appoint Mr. Long (Leo) Yi, who currently serves as the Chief Financial Officer of the Company, and Mr. Lan Su, who currently serves as the Chief Operating Officer of the Company, as new directors to fill vacancies on the Board, effective March 14 , 2025.
Max materiality 0.75 · Median 0.60 · Most common event other_material